BPC-157 Dosage and Protocol Guide
If you want the simple version, most BPC-157 conversations land in the 200 to 500 mcg per day range and run for about 2 to 6 weeks. From there, the real questions are usually route, once daily versus split dosing, and what that written mcg target looks like in actual syringe units. This page keeps the explanation practical and then points you to the calculator when you want the exact draw.
Want the quick version without doing all the math by hand? Open the full PeptideUniv app to plug in your vial, save the BPC-157 schedule, and come back to it later instead of rebuilding it from scratch.
Quick BPC-157 Dosage Reference
For fast scanning, this table summarizes the route, range, and cycle structures most often discussed around BPC-157 protocols.
Subcutaneous / injectable
200 to 500 mcg daily
Once daily or split twice daily
2 to 6 weeks
General recovery and connective-tissue-focused research discussions.
Oral / sublingual
250 to 500 mcg daily
Usually framed around gut-focused research and simpler routine planning.
Localized injectable
2 to 4 weeks
Used when protocol discussions focus on site-specific measurement and short observation windows.
What Is the Typical BPC-157 Dosage?
The most common educational BPC-157 range is about 200 to 500 mcg per day. In practice, many protocol examples are built around either a 250 mcg daily framework or a 500 mcg daily framework, depending on route, measurement preference, and cycle length.
That daily range is only the start of the answer. BPC-157 is discussed across injectable, oral, and localized-use contexts, so the dosage conversation changes depending on the research goal and how the protocol is being measured.
Cycle length matters almost as much as the daily amount. A 2-week schedule is often used as a short observation window, while 4-week and 6-week cycles are more common when the goal is to evaluate routine and adherence over a longer block.
Measurement is the final variable. A written mcg amount is not enough by itself. The usable dose depends on vial size, reconstitution volume, and how the target maps to syringe units.
Conservative daily framework
200 to 250 mcg per day
Often used as a lower-intensity reference point for route testing and routine consistency.
General recovery discussion
250 to 500 mcg per day
Commonly used in broad educational examples when the route is injectable.
Gut-focused planning
Usually tied to oral or sublingual discussions rather than localized injection structure.
Localized research discussion
200 to 500 mcg per day
Often framed around concentration checks, smaller volumes, and shorter observation windows.
BPC-157 Dosage by Administration Method
Injectable BPC-157 Dosage
Injectable BPC-157 is usually the route behind the most common dosage searches. Educational examples often place injectable protocols in the 200 to 500 mcg per day range, with some schedules using a single daily administration and others splitting the same daily total into two smaller doses.
This route is also the most dependent on reconstitution math. Once the peptide is mixed, the real question becomes how many units or how much volume corresponds to the planned mcg amount.
Oral BPC-157 Dosage
Oral or sublingual BPC-157 discussions usually overlap with gut-focused research language. The nominal daily amount may look similar on paper, but the protocol logic changes because the route is being used for a different kind of planning context.
In educational content, this route is often chosen when simplicity or non-injectable planning is the priority.
Intramuscular BPC-157 Dosage
More localized injectable planning is sometimes discussed for site-specific soft-tissue research. The overall daily range still tends to sit in the same general 200 to 500 mcg territory, but the protocol conversation shifts toward concentration, location, and repeatable measurement.
BPC-157 Protocol Structure
2-Week Protocol
A 2-week BPC-157 cycle is usually treated as a short observation window. It is useful when the goal is to test route, tolerance, and schedule practicality without committing to a longer framework.
4-Week Protocol
A 4-week protocol is a common middle ground because it is long enough to make daily adherence, vial usage, and measurement patterns easier to evaluate. Many educational examples use four weeks because it feels structured without implying indefinite use.
6-Week Protocol
A 6-week cycle is usually framed as an extended protocol rather than a default. It is typically paired with a reassessment point so the cycle remains intentional instead of drifting by habit.
2 weeks
Short observation window
Tolerance, route choice, and measurement accuracy
Often used when the goal is to test workflow before building a longer cycle.
4 weeks
Middle-ground cycle
Consistency, adherence, and vial usage
A common educational example because it is structured without becoming open ended.
6 weeks
Extended cycle
Whether the added duration still supports the research goal
Usually paired with a reassessment point rather than treated as an automatic default.
How Often Is BPC-157 Typically Used?
BPC-157 is commonly discussed in either once-daily or twice-daily schedules. A once-daily format is often used to keep the protocol simpler, easier to track, and less dependent on multiple measurement events.
Split dosing usually enters the conversation when the daily total is being divided for routine reasons or when a protocol is designed around morning-and-evening structure. The important distinction is that splitting changes timing, not necessarily the total daily amount.
In educational planning, the more useful question is usually not “once or twice” in the abstract, but which format is easier to measure accurately and repeat consistently over the full cycle.
Example BPC-157 Protocol
The table below is an educational framework only, not a personal recommendation. Its purpose is to show how dose range, frequency, and cycle length are commonly organized before measurement details are calculated.
Week 1
200 to 250 mcg daily
Once daily
Introductory range used for route selection and measurement checks.
Week 2
Once daily or split
Often where a protocol decides whether a simple single-dose routine is adequate.
Weeks 3 to 4
Educational example only if the cycle was designed around a higher daily range.
Weeks 5 to 6
Extension phase used only when the protocol intentionally exceeds a four-week cycle.
How to Measure and Plan BPC-157 Dosing
A BPC-157 protocol only becomes usable once the dose can be measured correctly. That means three numbers matter immediately: the amount of peptide in the vial, the amount of diluent used for reconstitution, and the syringe-unit conversion needed to reach the planned mcg dose.
This is where many dosage mistakes happen. A cycle written as “250 mcg daily” may sound precise, but it is incomplete until it is converted into a draw volume. The same written dose can map to very different unit markings depending on how the vial was mixed.
That is why dosage pages and calculators belong together. The protocol tells you the target amount; the calculator turns that target into something measurable.
BPC-157 Calculator or Planning Tool
Once you know the vial amount, reconstitution volume, and target mcg dose, the calculator saves a lot of avoidable hand math.
When you are ready to stop guessing at mL and syringe units, open the full PeptideUniv calculator. It will turn your BPC-157 target into an actual draw and let you save the schedule in one place.
For route-specific conversion support, see BPC-157 Dosage Calculator: Reconstitution and Units.
For adjacent context on recovery-focused research, the BPC-157 vs TB-500 comparison is a useful follow-on read.
Half-Life, Frequency, and Protocol Planning
BPC-157 half-life discussions are often brought up to justify schedule design, but in practice this is usually a supporting section rather than the main answer. The more immediate planning variables are still dose range, route, and cycle length.
Because the pharmacokinetic picture in humans is not well established, many protocol discussions fall back to what is measurable and repeatable: once-daily versus split dosing, total daily amount, and consistent routine across the cycle.
What Is BPC-157?
BPC-157 is a synthetic pentadecapeptide usually discussed in tissue repair, gut-support, and recovery-oriented research contexts. It is often grouped with regenerative peptides, which is why protocol pages tend to focus on cycle structure, administration method, and schedule logic.
Background matters, but for a dosage-focused page it belongs below the practical answer. Most users searching this page want the route, frequency, and cycle framework first.
Frequently Asked Questions About BPC-157 Dosage
Educational BPC-157 discussions usually land around 200 to 500 mcg per day. The exact framework depends on route, cycle length, and how the protocol is being measured.
Yes. Injectable, oral, and more localized protocol discussions often use similar nominal ranges on paper, but the planning logic changes because measurement, reconstitution, and research context change with the route.
Short educational examples often use 2 weeks, while more common protocol discussions run about 4 to 6 weeks. The useful planning habit is to define the cycle in advance and reassess instead of letting it drift indefinitely.
Both schedules are discussed. Some protocols favor a once-daily routine for simplicity, while others split the daily total into two administrations for timing or measurement reasons.
Use a calculator once the vial amount, reconstitution volume, and target mcg dose are already known. That is the step that converts a protocol idea into a usable syringe volume and unit marking.
Because the pharmacokinetic picture in humans is not well established. In practice, BPC-157 planning usually depends more on route, daily schedule, cycle length, and measurement consistency than on precise half-life assumptions.
Related BPC-157 Resources
Use these internal resources together when you want the background, the measurement layer, and the comparison context around BPC-157 in one place.
BPC-157 peptide guide: Mechanism, evidence quality, and broader recovery-focused context.
BPC-157 dosage calculator: Translate mcg targets into mL and U-100 syringe units after reconstitution.
BPC-157 vs TB-500: Compare two common recovery-focused peptide discussions without mixing their roles.
BPC-157 timeline guide: Review how anecdotal timelines differ from what research support actually looks like.
Educational only, not personal medical advice. For guidance about your own care, talk with a licensed healthcare professional.